Steven Cohen’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Steven Cohen's VKTX Position: Q3 2026 in Review
Steven Cohen reduced its Viking Therapeutics (VKTX) stake by 67% in Q3 2026, selling an estimated $11M and leaving 155,216 shares worth $5.06M. The position accounts for 0.01% of the portfolio, ranked #1802.
Steven Cohen first reported a position in VKTX in Q4 2022 and has held it in 8 quarters since. The position peaked at $18.5M in Q2 2026. 440 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Steven Cohen held 155,216 shares of Viking Therapeutics worth $5.06M as of Q3 2026.
- Steven Cohen sold 318,092 Viking Therapeutics shares in Q3 2026, an estimated $11M.
- Viking Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1802 holding.
- Steven Cohen first reported a position in Viking Therapeutics in Q4 2022 and has held it in 8 quarters since.
- Steven Cohen's Viking Therapeutics position peaked at $18.5M in Q2 2026.
- 440 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.